Lilly Existing

The chart shows the growth of an initial investment of $10,000 in Lilly Existing, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

As of Jun 9, 2026, the Lilly Existing returned 12.41% Year-To-Date and 20.67% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since Sep 9, 2010, Lilly Existing's average daily return is +0.08%, while the average monthly return is +1.54%. At this rate, an investment would double in approximately 3.8 years.

Historically, 65% of months were positive and 35% were negative. The best month was Apr 2020 with a return of +13.5%, while the worst month was Sep 2022 at -10.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.

On a daily basis, Lilly Existing closed higher 56% of trading days. The best single day was Apr 9, 2025 with a return of +11.3%, while the worst single day was Mar 16, 2020 at -12.6%.

Lilly Existing has an annualized alpha of 4.36%, beta of 1.08, and R2 of 0.95 versus S&P 500 Index. Calculated based on daily prices since September 09, 2010.

• This portfolio captured 121.98% of S&P 500 Index gains but only 97.09% of its losses - a favorable profile for investors.
• This portfolio generated an annualized alpha of 4.36% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
• With beta of 1.08 and R2 of 0.95, this portfolio moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.

Lilly Existing has an expense ratio of 0.05%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Lilly Existing ranks 42 for risk / return — on par with similar Portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below presents risk-adjusted performance metrics for Lilly Existing and compares them with S&P 500 Index.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Lilly Existing Sharpe ratios as of Jun 9, 2026 (values are recalculated daily):

• 1-Year: 2.11
• 5-Year: 0.83
• 10-Year: 1.00
• All Time: 0.98

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.59 to 2.46, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Lilly Existing compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Lilly Existing provided a 0.74% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Lilly Existing. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Lilly Existing was 32.42%, occurring on Mar 23, 2020. Recovery took 72 trading sessions.

The current Lilly Existing drawdown is 4.68%.

The chart below shows the rolling one-month volatility.